ArticleAmerican journal of cancer research2023

Preclinical trial of targeting the Hic-5-mediated pathway to prevent the progression of hepatocellular carcinoma.

Wen-Sheng Wu et al.PubMed ↗Full text ↗

No numbers read from the abstract.